Editorial Board Member from Current Oncology Featured in the 2022 Highly Cited Researchers List Published by Clarivate

Recently, Clarivate^TM revealed its 2022 list of Highly Cited Researchers™—individuals at universities, research institutes, and commercial organizations.

The scientists who were selected for this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with a citation frequency in the top 1% of academic subjects and the same year of publication in the Web of Science^TM database. Based on Web of Science Citation data, 6938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.

According to statistics, Dr. Hiroji Iwata (Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan), a member of the Editorial Board of Current Oncology (ISSN: 1718-7729), has been selected for the list of Highly Cited Researchers of Clarivate in 2022. He is being recognized for his high-quality scientific research achievements and outstanding contributions to professional fields. The Current Oncology journal office sincerely congratulates the elected Editorial Board Member and hopes that he continues to have an academically productive relationship with the journal.